➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Johnson and Johnson
Moodys
Dow
Medtronic

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

Ipratropium bromide - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for ipratropium bromide and what is the scope of patent protection?

Ipratropium bromide is the generic ingredient in three branded drugs marketed by Boehringer Ingelheim, Actavis Mid Atlantic, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb Inc, Landela Pharm, Mylan Speciality Lp, Nephron, Pharmascience Inc, Ritedose Corp, Roxane, Sun Pharm, Teva Pharms Usa, Watson Labs, Bausch And Lomb, and Hikma, and is included in twenty-six NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ipratropium bromide has sixty patent family members in thirty-eight countries.

There are eight drug master file entries for ipratropium bromide. Fourteen suppliers are listed for this compound.

Drug Sales Revenue Trends for ipratropium bromide

See drug sales revenues for ipratropium bromide

Recent Clinical Trials for ipratropium bromide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Theravance BiopharmaPhase 2
University of California, Los AngelesPhase 2
Mylan PharmaceuticalsPhase 2

See all ipratropium bromide clinical trials

Recent Litigation for ipratropium bromide

Identify potential future generic entrants

District Court Litigation
Case NameDate
ORTHO-MCNEIL PHARMACEUTICAL, INC. v. LUPIN PHARMACEUTICALS, INC.2006-10-17

See all ipratropium bromide litigation

Pharmacology for ipratropium bromide
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Medical Subject Heading (MeSH) Categories for ipratropium bromide
Synonyms for ipratropium bromide
(1R,3r,5S)-3-(3-hydroxy-2-phenylpropanoyloxy)-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide
(1R,5S)-3-((3-hydroxy-2-phenylpropanoyl)oxy)-8-isopropyl-8-methyl-8-azabicyclo[3.2.1]octan-8-ium bromide
(1S,3S,5R)-3-Tropyloxy-8-isopropyltropanium bromide
(3-endo,8-syn)-3-[(3-hydroxy-2-phenylpropanoyl)oxy]-8-isopropyl-8-methyl-8-azoniabicyclo[3.2.1]octane bromide
(8r)-3-alpha-Hydroxy-8-isopropyl-1-alpha-H,5-alpha-H-tropiumbromide-(+-)-tropate
(endo,Anti)-(1)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo(3.2.1)octane bromide
(endo,syn)-(+-)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide
(exo,Syn)-(1)-3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo(3.2.1)octane bromide
1-alpha-H,5-alpha-H-Tropanium, 3-alpha-hydroxy-8-isopropyl-, bromide, (+-)-tropate
22254-24-6
24358-20-1
3-alpha-Hydroxy-8-isopropyl-1-alpha-H,5-alpha-H-tropanium bromide (+-)-tropate
3alpha-hydroxy-8-isopropyl-1alphaH,5alphaH-tropanium bromide (+-)-tropate
58073-59-9
60251-88-9
8-Azoniabicyclo(3.2.1)octane, 3-(3-hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-, bromide, endo-
8-Isopropylnoratropine methobromide
AKOS015895324
AKOS030485952
ATEM
ATROPINE ISOPROPYLBROMIDE
Atrovent
Atrovent Hfa
BDBM50021892
Bromure d'ipratropium
Bromure d'ipratropium [INN-French]
Bromuro de ipratropio
Bromuro de ipratropio [INN-Spanish]
C20H30BrNO3
CHEBI:46659
CHEMBL1464005
DTXSID60858923
EINECS 244-873-8
EINECS 246-197-9
EINECS 261-098-0
EINECS 262-128-5
endo-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-isopropyl-8-methyl-8-azoniabicyclo(3.2.1)octane bromide
HMS2234J05
Ipratropii bromidum
Ipratropii bromidum [INN-Latin]
Ipratropium Bromide (anhydrous)
Ipratropium bromide [INN]
Ipratropium bromide anhydrous
Ipratropium Bromide'
ipratropium-bromide
Ipratropiumbromid
Ipratropiumbromid [German]
Itrop
MLS000069557
N-Isopropylnoratropinium bromomethylate
N-Isopropylnortropine tropate methobromide
Opera_ID_1621
Prestwick_279
Q424294
REGID_for_CID_657308
SC-14062
Sch 1000
SCHEMBL107906
SCHEMBL16762661
SCHEMBL3852
SCHEMBL3854
SMR000058764
UNII-VJV4X1P2Z1
VJV4X1P2Z1

US Patents and Regulatory Information for ipratropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 206543-001 Oct 27, 2016 AN RX No No   Start Trial   Start Trial   Start Trial
Apotex Inc IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075441-001 Mar 28, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
Actavis Mid Atlantic IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 075111-001 Apr 22, 1999 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Speciality Lp IPRATROPIUM BROMIDE ipratropium bromide SPRAY, METERED;NASAL 075552-001 Mar 31, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan Speciality Lp IPRATROPIUM BROMIDE ipratropium bromide SOLUTION;INHALATION 074755-001 Jan 10, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ipratropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004   Start Trial   Start Trial
Boehringer Ingelheim ATROVENT ipratropium bromide AEROSOL, METERED;INHALATION 019085-001 Dec 29, 1986   Start Trial   Start Trial
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004   Start Trial   Start Trial
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004   Start Trial   Start Trial
Boehringer Ingelheim ATROVENT HFA ipratropium bromide AEROSOL, METERED;INHALATION 021527-001 Nov 27, 2004   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Johnson and Johnson
Moodys
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.